TY - JOUR
T1 - Is autoimmunity a side-effect of interleukin 2 production?
AU - Krämer, Guido
AU - Schauenstein, Konrad
AU - Wick, Georg
N1 - Funding Information:
This work was supported by the Austrian Research Council (grants No. 4679, S-41/05).
PY - 1986/1/1
Y1 - 1986/1/1
N2 - Because it has a role in lymphocyte activation, interleukin 2 (IL-2) has been tried as a therapeutic agent in several types of immune dysfunction in animals and man. Here, Georg Wick and his colleagues discuss the possibility that IL-2 production initiates and perpetuates autoimmune disease, and express caution about the clinical use of IL-2.
AB - Because it has a role in lymphocyte activation, interleukin 2 (IL-2) has been tried as a therapeutic agent in several types of immune dysfunction in animals and man. Here, Georg Wick and his colleagues discuss the possibility that IL-2 production initiates and perpetuates autoimmune disease, and express caution about the clinical use of IL-2.
UR - http://www.scopus.com/inward/record.url?scp=0022905431&partnerID=8YFLogxK
U2 - 10.1016/0167-5699(86)90102-7
DO - 10.1016/0167-5699(86)90102-7
M3 - Article
AN - SCOPUS:0022905431
SN - 0167-5699
VL - 7
SP - 199
EP - 200
JO - Immunology Today
JF - Immunology Today
IS - 7-8
ER -